Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER Registry.
Ariane KleinIngrid BeckerKirsten MindenAnton HospachTobias SchwarzIvan FoeldvariBoris HugleMichael BorteFrank Weller-HeinemannFrank DresslerJasmin Kuemmerle-DeschnerPrasad Thomas OommenDirk FoellRalf TrauzeddelChristoph RietschelGerd HorneffPublished in: ACR open rheumatology (2019)
Surveillance of pharmacotherapy as provided by the BIKER registry is an import approach, especially for long-term treatment of children. Overall, tolerance was acceptable. Differences between biologics were noted and should be considered in daily patient care.